Phathom Pharmaceuticals, Inc. (PHAT)
8.36
-0.31
(-3.58%)
USD |
NASDAQ |
Sep 10, 13:28
Phathom Pharmaceuticals Total Liabilities (Quarterly) : 671.35M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 671.35M |
| March 31, 2026 | 642.08M |
| December 31, 2025 | 697.97M |
| September 30, 2025 | 662.82M |
| June 30, 2025 | 656.05M |
| March 31, 2025 | 632.58M |
| December 31, 2024 | 632.05M |
| September 30, 2024 | 574.16M |
| June 30, 2024 | 553.20M |
| March 31, 2024 | 505.00M |
| December 31, 2023 | 486.60M |
| September 30, 2023 | 254.76M |
| June 30, 2023 | 247.44M |
| March 31, 2023 | 234.20M |
| December 31, 2022 | 239.62M |
| September 30, 2022 | 228.35M |
| Date | Value |
|---|---|
| June 30, 2022 | 220.50M |
| March 31, 2022 | 111.01M |
| December 31, 2021 | 117.28M |
| September 30, 2021 | 124.90M |
| June 30, 2021 | 82.45M |
| March 31, 2021 | 82.02M |
| December 31, 2020 | 100.84M |
| September 30, 2020 | 74.50M |
| June 30, 2020 | 64.00M |
| March 31, 2020 | 55.22M |
| December 31, 2019 | 29.22M |
| September 30, 2019 | 232.17M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 2.188M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.08M |
| Shareholders Equity (Quarterly) | -344.27M |
| Debt to Equity Ratio | -1.603 |
| Current Ratio | 1.924 |
| Net Debt Paydown Yield | 0.29% |